JP2012522024A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522024A5
JP2012522024A5 JP2012502443A JP2012502443A JP2012522024A5 JP 2012522024 A5 JP2012522024 A5 JP 2012522024A5 JP 2012502443 A JP2012502443 A JP 2012502443A JP 2012502443 A JP2012502443 A JP 2012502443A JP 2012522024 A5 JP2012522024 A5 JP 2012522024A5
Authority
JP
Japan
Prior art keywords
salt
pharmaceutically applicable
acid
levorotatory
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012502443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522024A (ja
Filing date
Publication date
Priority claimed from CN2010101168675A external-priority patent/CN101780079B/zh
Application filed filed Critical
Publication of JP2012522024A publication Critical patent/JP2012522024A/ja
Publication of JP2012522024A5 publication Critical patent/JP2012522024A5/ja
Pending legal-status Critical Current

Links

JP2012502443A 2010-03-03 2010-06-17 左旋性アムロジピン複合薬組成物 Pending JP2012522024A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010116867.5 2010-03-03
CN2010101168675A CN101780079B (zh) 2010-03-03 2010-03-03 左旋氨氯地平复方药物组合物
PCT/CN2010/074004 WO2011106951A1 (zh) 2010-03-03 2010-06-17 左旋氨氯地平复方药物组合物

Publications (2)

Publication Number Publication Date
JP2012522024A JP2012522024A (ja) 2012-09-20
JP2012522024A5 true JP2012522024A5 (https=) 2014-03-06

Family

ID=42520307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012502443A Pending JP2012522024A (ja) 2010-03-03 2010-06-17 左旋性アムロジピン複合薬組成物

Country Status (6)

Country Link
US (1) US20120041035A1 (https=)
EP (1) EP2543373A4 (https=)
JP (1) JP2012522024A (https=)
CN (1) CN101780079B (https=)
CA (1) CA2754839C (https=)
WO (1) WO2011106951A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110755429A (zh) * 2018-07-26 2020-02-07 北京市石景山区高血压联盟研究所 一种复方降压药组合物、其制剂及其用途
CN111789843A (zh) 2019-04-08 2020-10-20 深圳奥萨医药有限公司 含氨氯地平、氯噻酮和阿米洛利的药物组合物
CN110372575A (zh) * 2019-07-10 2019-10-25 复旦大学 一种二氢吡啶钙拮抗剂共晶体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
US20050187262A1 (en) * 2004-01-12 2005-08-25 Grogan Donna R. Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
CN1960712B (zh) * 2004-05-21 2011-04-20 阿库-伯雷克技术公司 包含多个片段的刻痕药片
US7625940B2 (en) * 2005-07-01 2009-12-01 Accu-Break Technologies, Inc. Method of treating hypertension with a very low dose of chlorthalidone
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
CN101564536B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 一种治疗高血压的药物组合物缓控释制剂

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
JP2007302683A5 (https=)
JP2010535814A5 (https=)
JP2015147774A5 (https=)
RU2011113229A (ru) Соли n-[4-(1-цианоциклопентил)фенил]-2-(4-пиридилметил)амино-3-пиридинкарбоксамида
JP2012517962A5 (https=)
JP2013519683A5 (https=)
WO2009067686A3 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
WO2008048981A3 (en) Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
BRPI1006812B8 (pt) Forma cristalina de l-malato de n-(4-{[6,7-bis(metiloxi)-quinolin-4-il]oxi}fenil)-n'-(4-fluorfenil)ciclopropano-1,1-dicarboxamida, composições farmacêuticas e usos do mesmo
WO2010016683A3 (ko) 탈모의 예방, 치료, 또는 육모용 조성물
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
GB0710121D0 (en) Antifungal agents
BR112012015749A2 (pt) processos para produção de um agente farmaceuticamente ativo
JP2012507535A5 (https=)
JP2012522024A5 (https=)
EP1770085A4 (en) DIAMIDE DERIVATIVE, PREPARATION METHOD AND FUNGICIDE WITH THE DERIVATIVE AS ACTIVE AGENT
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof
ECSP077263A (https=)
DK2134712T3 (da) Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme
HRP20161135T1 (hr) Oblici u krutom stanju n-((s)-2,3-dihidroksi-propil)-3-(2-fluoro-4-jodo-fenilamino)-izonikotinamida
JP2015512948A5 (https=)
SI1954251T1 (sl) Sestavek s počasnim sproščanjem, ki ima kot aktivno učinkovino Fe sol, postopek njegove priprave in uporabe